JPRN-UMIN000026117招募中未知
Occult Hepatitis C virus in the liver-transplanted patients received anti-HCV therapy - Occult Hepatitis C virus in the liver-transplanted patients
Department of Gastroenterology and Hepatology, Nagasaki University Hospital0 个研究点目标入组 70 人开始时间: 2017年2月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients who were judged to be inappropriate for this study.
研究者
相似试验
招募中
不适用
Hepatitis C virus-related liver disease cohort study in KoreaCertain infectious and parasitic diseasesKCT0000306Korea Centers for Disease Control and Prevention100
进行中（未招募）
1 期
PHASE II CLINICAL STUDY ON THE USE OF HCV+ DONORS FOR SOLID ORGAN TRANSPLANTATION.SE OF POSITIVE DONORS FOR INFECTION OF THE HEPATITIS VIRUS FOR THE TRANSPLANTATION OF SOLID ORGANS IN AN ENDEMIC AREA FOR HEPATITIS C WITH LOW RATE OF DONATIONS FROM CADAVERS: OPEN PHASE II CLINICAL STUDY.MedDRA version: 20.0Level: PTClassification code 10024714Term: Liver transplantSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 21.1Level: PTClassification code 10063837Term: Reperfusion injurySystem Organ Class: 10047065 - Vascular disordersMedDRA version: 20.1Level: PTClassification code 10058060Term: Graft complicationSystem Organ Class: 10022117 - Injury, poisoning and procedural complicationsEUCTR2018-003640-23-ITISTITUTO MEDITERRANEO PER I TRAPIANTI E TERAPIE AD ALTA SPECIALIZZAZIONE - ISMETT212
进行中（未招募）
1 期
Hepatitis C in renal transplant recipients – Safety and efficacy of a conversion of immunosuppression to high-dose cyclosporine A and its impact on HCV-replication, parameters of liver function and glucose tolerance. An open label trial.renal transplant recipients with hepatitis CMedDRA version: 14.1Level: LLTClassification code 10057394Term: Hepatitis C positiveSystem Organ Class: 10022891 - InvestigationsEUCTR2011-002267-26-ATMedizinische Universität Wien50
招募中
3 期
Comparison of the degree and speed of virologic response to two treatment options in patients with chronic Hepatitis C.ACTRN12615001111561Mostafa Yakoot200
已完成
3 期
The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver TransplantationHepatitis C Recurrence After Liver TransplantNCT01707849Hospital Vall d'Hebron18